Universal Ibogaine Inc.
IBO.V
TSX
| 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | 04/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -635.50K | -164.60K | -153.10K | -201.60K | -359.30K |
| Total Depreciation and Amortization | 59.30K | 60.60K | 61.70K | 65.90K | 53.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 274.30K | 12.80K | 10.20K | 93.70K | 31.80K |
| Change in Net Operating Assets | -67.40K | 40.70K | -54.60K | 46.30K | 147.00K |
| Cash from Operations | -369.40K | -50.40K | -135.80K | 4.30K | -127.10K |
| Capital Expenditure | -14.20K | -6.80K | -22.40K | 27.50K | -31.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -14.20K | -6.80K | -22.40K | 27.50K | -31.60K |
| Total Debt Issued | -- | -- | -- | -53.70K | 380.00K |
| Total Debt Repaid | -32.70K | -32.30K | -38.30K | -28.60K | -4.10K |
| Issuance of Common Stock | 992.80K | 317.20K | 100.00K | 0.00 | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -334.00K | -3.20K | -- | -- | -- |
| Cash from Financing | 461.40K | 208.70K | 45.40K | -61.70K | 277.60K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 77.80K | 151.50K | -112.80K | -29.80K | 118.90K |
